Division of Digestive Diseases, Department of Internal Medicine,
and Departments of Pharmacology and Molecular Biophysics and
Physiology, Rush University Medical Center, Chicago, Illinois 60612
Using
oxidant-induced hyperpermeability of monolayers of intestinal (Caco-2)
cells as a model for the pathophysiology of inflammatory bowel disease
(IBD), we previously showed that oxidative injury to the F-actin
cytoskeleton is necessary for the disruption of monolayer barrier
integrity. We hypothesized that this cytoskeletal damage is caused by
upregulation of an inducible nitric oxide (NO) synthase (iNOS)-driven
pathway that overproduces reactive nitrogen metabolites (RNMs) such as
NO and peroxynitrite (OONO
), which cause actin nitration
and disassembly. Monolayers were exposed to
H2O2 or to RNMs with and without pretreatment
with antioxidants or iNOS inhibitors. H2O2
concentrations that disassembled and/or disrupted the F-actin
cytoskeleton and barrier integrity also caused rapid iNOS
activation, NO overproduction, and actin nitration. Added
OONO
mimicked H2O2; iNOS
inhibitors and RNM scavengers were protective. Our results show that
oxidant-induced F-actin and intestinal barrier disruption are caused by
rapid iNOS upregulation that further increases oxidant levels; a
similar positive feedback mechanism may underlie the episodic
recurrence of the acute IBD attack. Confirming these mechanisms in vivo
would provide a rationale for developing novel anti-RNM therapies for IBD.
inflammatory bowel disease; G-actin; nitration; oxidation; disassembly; nitric oxide; peroxynitrite; Caco-2 cells; inducible
nitric oxide synthase
 |
INTRODUCTION |
UNDER NORMAL
CONDITIONS, the gastrointestinal (GI) mucosa is a highly
selective barrier that prevents the passage of toxic proinflammatory
molecules from the gut lumen into the mucosa and the circulation
(12, 20, 27). Under abnormal conditions, loss of GI
barrier integrity can permit the penetration of normally excluded
luminal substances (e.g., endotoxin and microbes) into or across the
mucosa, which can lead to the initiation and/or perpetuation of
inflammatory processes and mucosal injury. This injury and the ensuing
loss of mucosal barrier integrity have been implicated in the
pathophysiology of a wide range of inflammatory disorders including
inflammatory bowel disease (IBD) (12, 16, 20, 27). The
pathogenesis of mucosal barrier dysfunction in IBD remains poorly
understood, but several studies, including ours (2, 6, 8),
have shown that chronic gut inflammation is associated with high levels
of reactive oxygen metabolites (ROMs) and that these oxidants appear to
be involved in causing mucosal barrier dysfunction (2, 8, 26,
30). However, the precise biochemical mechanisms have not been established.
While investigating these mechanisms with monolayers of intestinal
cells as a model of barrier function, we (2, 5-8)
demonstrated that oxidant-induced barrier disruption is dependent on
the disruption of the cytoskeleton. For example, we observed that loss
of barrier integrity required disruption of the polymerized (F)-actin
cytoskeleton. The idea that cytoskeletal instability in general and
actin filament disruption in particular could be major contributing
factors to loss of barrier integrity is consistent with other studies
in which we have shown the importance of cytoskeletal stability in GI
healing in vivo (3, 4) as well as in vitro (2, 5-10a, 25). It is also consistent with the known roles of actin in
cell function. Actin is one of the most abundant proteins in the
eukaryotic cells, with the ability to polymerize into filaments of
highly dynamic
-double helices (11, 38). In epithelial
cells, such filaments constitute a dense cross-linked actin cortex
located on the inner side of the plasma membrane. The actin
cytoskeleton also contains filamentous stress fibers that traverse the
cytosol and short fibers that extend into the lamellipodia in motile
cells. This structural component is essential in maintaining normal
cellular physiology, structure, locomotion, and support functions
(2, 11, 29, 38, 39).
Our current investigation also derives from recent reports that
elevated levels of peroxynitrite (ONOO
) may be an
essential factor in tissue injury during IBD (23, 34, 35).
Indeed, studies from our laboratory on ethanol-induced intestinal
injury, as well as those from other laboratories, have shown that
inducible nitric oxide (NO) synthase (iNOS) activation can lead to NO
overproduction (8, 14, 36, 40) and that the injurious
effects of NO overproduction appear to be mediated by
ONOO
, the product of the reaction of NO with superoxide
anions (O
·) (7, 18, 22, 34).
Accordingly, the objectives of the current study were to determine
1) whether disruption of the actin cytoskeleton and loss of
barrier integrity after exposure to oxidants such as
H2O2 are associated with elevated iNOS activity
and with elevated levels of reactive nitrogen metabolites (RNMs) such
as NO and ONOO
, 2) whether exposure of cells
to these RNMs mimics the effects of oxidants, and 3) whether
agents that scavenge these RNMs (antioxidants) or inhibit their
formation (iNOS inhibitors) are protective.
 |
MATERIALS AND METHODS |
Cell culture.
Intestinal Caco-2 cells (American Type Culture Collection, Manassas,
VA) grown for barrier integrity work were split at a ratio of 1:2 and
seeded at a density of 200,000 cells/cm2 in 0.4-µm
collagen I cell culture inserts (0.3-cm2 growth surface;
Biocoat, Becton Dickinson Labware, Bedford, MA), and experiments were
performed at least 7 days after confluence. The utility, maintenance,
and characterization of this cell line and the preparation of the
monolayers of Caco-2 cells have been previously described (9, 17,
39).
Determination of epithelial barrier function by fluorometry.
The barrier integrity of Caco-2 monolayers was determined by measuring
the apical-to-basolateral flux of fluorescein sulfonic acid [(FSA);
200 µg/ml; 478 Da; Molecular Probes, Eugene, OR] as previously
described (2, 6, 39). After the treatments, fluorescent
signals from the samples were quantitated with a fluorescence multiplate reader (FL 600, Bio-Tek Instruments) with the excitation and
emission spectra for FSA set as excitation = 485 nm and emission = 530 nm. Clearance (Cl) was calculated with the formula Cl
(nl · h
1 · cm
2) = Fab/([FSA]a × S), where Fab is the
apical-to-basolateral flux of FSA in light units per hour,
[FSA]a is the concentration at baseline in light units
per nanoliter, and S is the surface area (0.3 cm2) (2, 8). Simultaneous controls were
performed with each experiment.
Assay of NOS activity.
Cells grown to confluence were removed by scraping, centrifuged, and
homogenized on ice in a buffer containing 50 mM Tris · HCl, 0.1 mM EDTA, 0.1 mM EGTA, 12 mM 2-mercaptoethanol, and 1 mM
phenylmethylsulfonyl fluoride (pH 7.4). The conversion of L-[3H]arginine (L-Arg; Amersham,
Arlington Heights, IL) to L-[3H]citrulline
was measured in the homogenates by scintillation counting as described
previously (7, 8, 36). As we previously reported (7,
8), experiments in the absence of NADPH and the presence of the
NOS inhibitor NG-nitro-L-arginine (1 mM) were used to assess the extent of
L-[3H]citrulline formation that was
independent of any NOS activity. Experiments in the presence of NADPH,
without Ca2+ and with 5 mM EGTA, determined
Ca2+-independent NOS (iNOS) activity. Experiments in the
presence of NADPH and Ca2+ determined
Ca2+-dependent NOS [constitutive NOS (cNOS)] activity. In
selected experiments, we added the isoform-selective iNOS inhibitor
L-N6-(1-iminoethyl)lysine
(L-NIL, 1 mM). Protein concentrations were determined by
the Bradford method (13).
Western blot analysis of the level of iNOS
protein.
After treatment, the cells were washed once with cold PBS, scraped in 1 ml of cold PBS, and harvested in a standard anti-protease cocktail. For
immunoblotting, samples (25 µg protein/lane) were added to SDS buffer
(250 mM Tris · HCl, pH 6.8, 2% glycerol, and 5%
mercaptoethanol), boiled for 5 min, and then separated on 7.5% SDS-PAGE gels. Subsequently, the proteins were transferred to nitrocellulose membranes and blocked in 3% BSA for 1 h, followed by several washes in Tris-buffered saline. The immunoblotted proteins were incubated for 2 h in Tween 20, Tris-buffered saline, and 1%
BSA with the primary antibody (mouse monoclonal anti-human iNOS at
1:3,000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). A
horseradish peroxidase (HRP)-conjugated goat anti-mouse antibody
(Molecular Probes) was used as a secondary antibody at 1:3,000
dilution. The membranes were visualized by enhanced chemiluminescence (Amersham) and autoradiography (7, 37).
Chemiluminescence analysis of NO concentration in
cultures.
NO production was assessed by a novel chemiluminescence procedure
(1, 7). Briefly, cells were homogenized by sonication, and
the endogenous nitrate (NO
) and nitrite
(NO
) and the metabolic degradation products of NO
were then reduced to NO with the use of vanadium(III) (Sigma, St.
Louis, MO) and HCl at 90°C before the measurement of NO concentration
by chemiluminescence analysis. Chemiluminescence was measured with a
Sievers NO 280 analyzer (NOA, Boulder, CO). NO (expressed in µM) was
calculated by comparison with the chemiluminescence of a standard
solution of NaNO2. The absolute NO values were reported as
micromoles per 106 cells.
Determination of cell oxidative stress.
Oxidative stress was assessed by measuring the conversion of a
nonfluorescent compound, 2',7'-dichlorofluorescein diacetate (DCFD;
Molecular Probes), into the fluorescent dye dichlorofluorescein (DCF)
as previously described (8). The dependence of the assay on O
· generation was shown by adding an active
superoxide radical scavenger, superoxide dismutase (SOD, 300 U/ml), or an inactive superoxide radical scavenger,
heat-inactivated SOD (iSOD). Briefly, monolayers grown in 96-well
plates were preincubated with the membrane-permeant DCFD (10 µg/ml
for 30 min) before the subsequent treatments. Fluorescent signals
(i.e., DCF fluorescence) from the samples were quantitated with a
fluorescence multiplate reader set at an excitation wavelength of 485 nm and an emission wavelength of 530 nm.
Immunofluorescent staining and high-resolution laser scanning
confocal microscopy of the actin cytoskeleton.
Cells from monolayers were fixed in cytoskeleton stabilization buffer
and then postfixed in 95% ethanol as previously described (2,
9). Monolayers of cells were subsequently processed for
incubation with FITC-phalloidin (specific for F-actin staining; Sigma)
at 1:40 dilution for 1 h at 37°C and then were mounted in
Aquamount. The samples were examined by both standard fluorescence microscopy and ultra high-resolution laser scanning confocal microscopy (LSCM; Carl Zeiss). Cell monolayers on slides were analyzed in a
blinded fashion using LSCM with a ×63 oil immersion plan-apochromat objective, NA 1.4 (Zeiss). An argon laser (wavelength = 488 nm) was used to examine FITC-labeled cells, and the cytoskeletal elements were examined for their overall morphology, orientation, and disruption as previously described (2, 9).
Actin fractionation and quantitative Western immunoblotting of
F-actin and monomeric actin.
F-actin and monomeric (G)-actin were isolated as we previously
described (2, 5). Briefly, cells were pelleted by
centrifugation at low speed (700 rpm for 7 min at 4°C) and
resuspended in actin stabilization-extraction buffer (0.1 M PIPES, pH
6.9, 30% glycerol, 5% DMSO, 1 mM MgSO4, 10 µg/ml of a
standard anti-protease cocktail, 1 mM EGTA, and 1% Triton X-100) at
room temperature for 20 min. F- and G-actin were separated after a
series of ultracentrifugation and extraction steps. Fractionated actin
samples were flash frozen in liquid N2 and stored at
70°C until immunoblotting was performed. For immunoblotting,
samples (5 µg of protein) were placed in a standard SDS buffer,
boiled for 5 min, and then subjected to PAGE (7.5% gel)
(9). To quantify the relative levels of actin, the optical
density (OD) of the bands corresponding to the immunoradiolabeled actin
was measured with a laser densitometer (2).
Immunoblotting determination of actin oxidation and actin
nitration.
Oxidation and nitration of the actin cytoskeleton were assessed,
respectively, by measuring protein carbonyl and nitrotyrosine formation. Carbonylation and nitrotyrosination of actin were determined in a manner similar to the quantitative blotting of actin (2, 8). To avoid the unwanted oxidation of the actin samples, all buffers contained 0.5 mM dithiothreitol and 20 mM
4,5-dihydroxy-1,3-benzenedisulfonic acid (Sigma). To determine
the carbonyl content, samples were blotted to a polyvinylidene
difluoride membrane and then subjected to successive 5-min incubations
in 2 N HCl and 2,4-dinitrophenylhydrazine (DNPH; 100 µg/ml in 2 N
HCl; Sigma). Membranes were then washed three times in 2 N HCl
and subsequently washed seven times in 100% methanol (5 min each),
followed by blocking for 1 h in 5% BSA in 10× PBS-Tween 20 (PBS-T). Immunologic evaluation of carbonyl formation was performed for
1 h in 1% BSA-PBS-T buffer containing anti-DNPH (1:25,000
dilution; Molecular Probes). The membranes were then incubated with a
HRP-conjugated secondary antibody (1:4,000 dilution; Molecular Probes)
for 1 h. To determine nitrotyrosine content, after the blocking
step listed above (i.e., BSA-PBS-T buffer), the membranes were probed
for nitrotyrosine by incubation with 2 µg/ml of monoclonal
anti-nitrotyrosine antibody for 1 h (Upstate Biotechnology, Lake
Placid, NY) followed by the HRP-conjugated secondary antibody as
described for carbonylation. The wash steps and film exposure
were as in a standard Western protocol (8, 9). The
relative levels of oxidized or nitrated actin were then quantified by
measuring the OD of the bands corresponding to anti-DNPH or
anti-nitrotyrosine immunoreactivity with a laser densitometer.
Immunoreactivity was expressed as the percentage of carbonyl or
nitrotyrosine formation (OD) in the treatment group compared with the
maximally oxidized or nitrated tubulin standard. Oxidized or nitrated
tubulin standards were run concurrently with the corresponding
treatment groups.
Statistical analysis.
Data are presented as means ± SE. All experiments were carried
out with a sample size of at least 4-6 observations/group. Statistical analysis between or among groups was carried out with analysis of variance followed by Dunnett's multiple-range test (19). Correlational analyses were done with the Pearson
test for parametric analysis or, when applicable, the Spearman test for
nonparametric analysis. A P value < 0.05 was deemed to
represent statistical significance.
 |
RESULTS |
Evidence that oxidant-induced leakiness of the intestinal barrier
involves activation of iNOS.
We first confirmed our earlier finding (2) that exposure
of Caco-2 cell monolayers for 30 min to increasing concentrations of
H2O2 causes hyperpermeability of the intestinal
barrier in the monolayers in a dose-dependent manner. This is indicated
by the increased clearance of FSA (Fig.
1). We now show that preincubation (1 h)
with a selective iNOS inhibitor (L-NIL, 1 mM) significantly attenuates (
72%) this effect. This inhibition was significantly lower (
50%) at the higher oxidant doses: FSA clearance (in
nl · h
1 · cm
2) = 1,287 ± 72 for L-NIL + 5 mM
H2O2 vs. 2,589 ± 89 for 5 mM
H2O2 alone. A substrate for NOS,
L-Arg (3 mM, 48-h exposure), by itself did not
significantly affect permeability, but it did synergize with a
nondamaging concentration of H2O2 (0.05 mM) to
disrupt monolayer barrier integrity. Moreover, L-Arg
potentiated the loss of monolayer barrier integrity in the presence of
damaging H2O2 concentrations (0.5 mM
H2O2 is shown). In both cases, potentiation was
prevented by L-NIL.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Injurious effects of H2O2 and
protective effects of pretreatment with
L-N6-(iminoethyl)lysine
(L-NIL). L-NIL, a selective inhibitor of
inducible nitric oxide synthase (iNOS), protected against loss of
Caco-2 monolayer barrier integrity as assessed by fluorescein sulfonic
acid (FSA) clearance. Monolayers (n = 6 observations/group for Figs. 1-11) were pretreated with 1 mM
L-NIL 1 h before subsequent exposure to noninjurious
(0.05 mM) or injurious (0.5 mM) concentrations of
H2O2 for 30 min. In selected experiments,
monolayers were preincubated with L-arginine
(L-Arg) 48 h before the aforementioned treatments. FSA
clearance was calculated as apical to basolateral flux of FSA divided
by the concentration of probe in the apical chamber. *P < 0.05 compared with vehicle or 0.05 mM H2O2.
+P < 0.05 compared with 0.5 mM
H2O2 alone. ++P < 0.05 compared with L-Arg + H2O2. &P < 0.05 compared with L-NIL + H2O2.
#P < 0.05 compared with the corresponding
0.05 mM or 0.5 mM H2O2 alone.
|
|
Evidence that NO, oxidative stress, and
ONOO
are also involved in oxidant-induced
monolayer barrier dysfunction.
Pretreatment of monolayers with the NO and ONOO
scavengers urate (
66%) and L-cysteine (
74%) or the
O
· scavenger SOD (
72%), which is similar to
L-NIL, significantly attenuated
H2O2-induced monolayer hyperpermeability (Fig.
2). Pretreatment with iSOD was not
protective. iSOD by itself did not injure cells (clearance = 28 ± 9 vs. 22 ± 8 nl · h
1 · cm
2 for vehicle).
The failure to elicit 100% protection by the aforementioned antioxidants was not due to technical problems because the addition of
catalase, an H2O2 scavenger (1,000 U/ml),
elicited 99% protection.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Protective effect of antioxidants against
H2O2-induced disruption of barrier integrity in
Caco-2 monolayers. Permeability of monolayers was again assessed by FSA
clearance. Monolayers were pretreated with 0.5 mM urate, 1 mM
L-cysteine, or 300 U/ml superoxide dismutase (SOD; a
superoxide anion scavenger) or heat-treated (inactive) SOD (iSOD),
before exposure to H2O2. Clearance was
determined as in Fig. 1. *P < 0.05 compared with
vehicle. +P < 0.05 compared with
H2O2 alone. ++P < 0.05 compared with SOD-pretreated monolayers.
|
|
Figure 3A
shows that doses of H2O2 that caused
hyperpermeability also caused significant increases in
Ca2+-independent, L-NIL-inhibitable NOS (i.e.,
iNOS) activity in lysates of Caco-2 monolayers compared with control
monolayers, which displayed low iNOS activity levels. In contrast,
neither oxidants nor L-NIL or their combination had any
effect on Ca2+-dependent cNOS (oxidant, 0.31 ± 0.10;
L-NIL, 0.33 ± 0.07; L-NIL plus oxidant,
0.30 ± 0.08; vehicle alone, 0.29 ± 0.12 pmol · min
1 · mg protein
1).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
A: upregulation of iNOS activity induced by
H2O2 in Caco-2 monolayers. Cell monolayers were
pretreated for 1 h with L-NIL (1 mM) or vehicle and
subsequently exposed to H2O2 for 30 min.
*P < 0.05 compared with vehicle.
+P < 0.05 compared with
H2O2. B: effects of
H2O2 on iNOS protein levels in Caco-2 cell
monolayers as shown by Western immunoblotting. Monolayers were exposed
to nondamaging (0.05 mM) or damaging (0.5 mM)
H2O2 or control (vehicle) for 30 min. Damaging
concentrations of H2O2 resulted in a large
increase in levels of iNOS protein in cell fractions. In contrast,
control and nondamaging concentrations of H2O2
were associated with a normal and basal level of iNOS (~130 kDa).
Western blots of cell monolayer fractions were processed sequentially
with monoclonal anti-human iNOS and horseradish peroxidase-conjugated
secondary antibodies. The region of gel shown was between the 126,000 and 218,000 prestained molecular weights, which were run in adjacent
lanes; ~ denotes approximate molecular weight for iNOS. C:
concentrations of nitric oxide (NO) in the supernatant of homogenates
of intestinal cell monolayers exposed to H2O2.
NO levels were assessed by a sensitive chemiluminescence assay (see
MATERIALS AND METHODS). Conditions were identical to those
in A. *P < 0.05 compared with vehicle.
+P < 0.05 compared with
H2O2.
|
|
Figure 3B depicts a representative Western blot showing that
H2O2 significantly increased iNOS protein
levels; control monolayers exhibited low basal levels of iNOS protein.
The corresponding ODs were control, 888 ± 92; nondamaging
concentrations (0.05 mM) of H2O2, 924 ± 81; and damaging concentrations (0.5 mM) of
H2O2, 4,251 ± 107.
Figure 3C shows NO overproduction in cell monolayers exposed
to H2O2. NO overproduction was almost
completely prevented by pretreating the monolayers with
L-NIL. A nondamaging concentration of
H2O2 (0.05 mM), one that did not significantly
increase permeability, induced neither iNOS activity (0.40 ± 0.15 vs. 0.35 ± 0.04 pmol · min
1 · mg
protein
1 for vehicle) nor NO overproduction (1.93 ± 0.42 vs. 1.72 ± 0.19 µmol/106 cells for vehicle).
Figure 4 shows the time course for
increases in iNOS protein, iNOS activity, and NO levels. These effects
of H2O2 were rapid; more than two-thirds of the
changes occurred within the first 30 min. Maximal changes were 4.8-fold
for iNOS protein, 10.1-fold for iNOS activity, and 10.1-fold for NO
levels.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Time course for induction of iNOS and increases in NO.
Data are means ± SE. Units: pmol/mg protein for iNOS activity;
10 3 × optical density for iNOS protein levels;
µmoles/106 cells for NO levels. Cells were exposed to 0.5 mM H2O2 at time 0.
|
|
H2O2 also significantly increased the
fluorescence of DCF (Fig. 5), a marker
for oxidative stress. This increase was prevented by L-NIL,
by NO and ONOO
scavengers (L-cysteine is
shown), and by O
· scavengers (SOD but not iSOD).
These data suggest that iNOS activation and its reaction products
contribute to the increase in oxidative stress in the cell. These data
also confirm the generation of NO and O
· after
exposure to H2O2.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Oxidative stress in cell monolayers that is induced by
H2O2 is attenuated by the iNOS inhibitor
L-NIL or by antioxidants (L-cysteine or SOD).
Oxidative stress was assessed by the dichlorofluorescein (DCF)
fluorescence assay. Conditions were as in Figs. 2 and 3A.
*P < 0.05 compared with vehicle.
+P < 0.05 compared with
H2O2. ++P < 0.05 compared with SOD-preexposed monolayers.
|
|
NO- and ONOO
-dependent
mechanisms in the loss of F-actin cytoskeletal
integrity.
Pretreatment of Caco-2 monolayers with L-NIL or with the
above noted antioxidants protected the F-actin cytoskeleton against most of the H2O2-induced damage, an outcome
that was quantitated with the use of LSCM and by calculating changes in
the percentage of cells displaying normal actin (Fig.
6). A 0.5 mM dose of
H2O2 decreased the proportion of cells showing
normal actin by 49%. The extent of this damage was inhibited 90% by
L-NIL, 84% by urate, 81% by L-cysteine, and
88% by SOD. These effects on the actin cytoskeleton by
L-NIL and antioxidants paralleled their protective effects
on barrier function.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Protective effects of L-NIL or antioxidants
against oxidant-induced actin cytoskeletal disruption.
L-NIL- or antioxidant-pretreated cells maintained a high
percentage of Caco-2 cells displaying normal F-actin cytoskeleton in
monolayers exposed to oxidant (H2O2) as
assessed by high-resolution laser scanning confocal microscopy (LSCM).
Conditions were as in Figs. 2 and 3A. *P < 0.05 compared with vehicle. +P < 0.05 compared with H2O2.
++P < 0.05 compared with SOD-pretreated
monolayers.
|
|
Immunofluorescent staining, as used in the experiments shown in Fig.
7, revealed that pretreatment with
L-NIL before H2O2 protected the
actin cytoskeleton against injury. This was shown by a normal smooth
and continuous pattern of the actin "ring" at the areas of
cell-cell contact (Fig. 7C), which was comparable in
appearance to the control monolayers (Fig. 7A) and quite
different from the injured (i.e., disrupted, fragmented, condensed, and beaded) appearance of actin in cells exposed to oxidants (Fig. 7B).

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 7.
Fluorescent staining of the
F-actin cytoskeleton assessed by high-resolution LSCM in intestinal
cell monolayers incubated with isotonic saline (control; a),
0.5 mM H2O2 (b), or 1 mM
L-NIL (c) followed by
H2O2. Controls revealed a normal, continuous,
and smooth architecture of the actin ring or cortex at areas of
cell-cell contact. In contrast, H2O2-exposed
monolayers exhibited areas of actin disruption, beading, and
fragmentation. In cells pretreated with L-NIL, actin
appeared normal and resembled the morphology detected in the control
monolayers. Bar, 25 µm.
|
|
Quantitative Western immunoblotting analysis (Fig.
8A)
demonstrated that 0.5 mM H2O2 decreased the
fraction of stable (polymerized) F-actin by 31% and increased the
fraction of monomeric G-actin. Pretreatment with L-NIL or
antioxidants attenuated this effect (L-NIL,
82%; urate,
94%; L-cysteine,
88%; SOD,
82%).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
A: quantitative immunoblotting analysis of the
levels of polymerized F-actin (an index of stability) and monomeric
G-actin (an index of disassembly) in Caco-2 cell monolayers. Monolayers
were preincubated with L-NIL or antioxidants before
incubation with 0.5 mM H2O2. Conditions were
similar to those in Figs. 2 and 3A. Actin fractions were
analyzed by SDS-PAGE and processed for autoradiography and then for
densitometry to obtain the optical density of the bands corresponding
to immunoradiolabeled actin. Percent polymerization of actin = [F/total actin pool (F + G)]. *P < 0.05 compared with vehicle. +P < 0.05 compared
with H2O2. ++P < 0.05 compared with SOD-preincubated monolayers. B: Western
immunoblot photomicrograph of the F-actin (Triton insoluble) extracts
after identical treatments as in A. F-actin fractions were
analyzed by SDS-PAGE and Western immunoblots with monoclonal anti-actin
as primary antibody followed by horseradish peroxidase-conjugated
secondary antibody and subsequently processed for X-ray film exposure.
The corresponding optical densities for F-acting fractions are, from
right to left: Control (isotonic saline), 11,135;
0.5 mM H2O2, 7,843; L-NIL + 0.5 mM H2O2, 10,369; actin standard (43 kDa);
second actin standard; SOD + 0.5 mM H2O2,
10,094; iSOD + 0.5 mM H2O2, 7,903;
L-cysteine + 0.5 mM H2O2,
10,232.
|
|
A representative Western blot gel (Fig. 8B) demonstrated
that preincubation with L-NIL or antioxidants enhanced the
autoradiographic band density for F-actin extracted from the monolayers
to the control level, independently confirming enhanced assembly (and stabilization) of actin.
To measure the "footprints" of ONOO
formation, namely
nitrotyrosine and carbonyl moieties, the F-actin cytoskeleton of the cell monolayers was fractionated and isolated. We then used a sensitive
quantitative immunoblot (Fig.
9A).
H2O2 resulted in the nitration and oxidation of
the F-actin cytoskeleton. For instance, the fraction of F-actin that
was nitrated by 0.5 mM H2O2 was equal to
0.65 ± 0.03%, and this was similar to the fraction of
F-actin that was carbonylated (0.70 ± 0.015%, ratios normalized
to a nitrated or oxidized actin standard run concurrently). Figure
9B shows that pretreatment of cell monolayers with the iNOS
inhibitor L-NIL or with any of our antioxidants
significantly protected against the nitration and carbonylation of the
F-actin filaments (nitration shown in Fig. 9B:
L-NIL,
93%; urate,
85%; L-cysteine,
98%; SOD,
73%). There was a significant (P < 0.05) positive correlation between 1) F-actin disruption and
2) F-actin nitration (r = 0.98) or oxidation
(r = 0.96). These data are consistent with the
protective effects of these same antioxidants against barrier
dysfunction.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 9.
A: immunoblot analysis of both
anti-dinitrophenylhydrazone (DNP) and anti-nitrotyrosine
immunoreactivity of the cytoskeletal F-actin pool in Caco-2 monolayers
exposed to H2O2. These represent, respectively,
carbonylation (oxidation or anti-DNP) or nitration of actin. Oxidation
or nitration was expressed as the following fraction: carbonyl or
nitrotyrosine formation (i.e., optical density) in the treatment group
divided by the oxidized (or nitrated) actin standard.
*P < 0.05 compared with vehicle. B:
quantitative immunoblotting showing the protective effects of
L-NIL and antioxidants against
H2O2-induced nitration of polymerized F-actin
in Caco-2 cells. Conditions as in Figs. 2 and 3A. Nitration
was expressed as described in A. *P < 0.05 compared with vehicle. +P < 0.05 compared
with H2O2. ++P < 0.05 compared with SOD-pretreated monolayers.
|
|
ONOO
compounds mimic the ability of
H2O2 to cause
F-actin cytoskeletal instability and barrier disruption.
If ONOO
mediates oxidant-induced damage, then chemically
authentic ONOO
or compounds capable of generating
ONOO
should mimic H2O2 and cause
similar disruption of the F-actin cytoskeleton and monolayer barrier,
and these effects should be inhibited by the same antioxidants that
inhibit the disruption that is caused by H2O2.
First, we found that ONOO
and ONOO
generators [e.g., 3-morpholinosydnonimine (SIN-1), a NO and
O
· donor, and
S-nitroso-N-acetylpenicillamine, a NO donor] in
combination with xanthine plus xanthine oxidase (an
O
· donor) significantly and dose dependently
disrupted the monolayer barrier (data not shown), which confirmed our
previous findings (7) that these ONOO
compounds increase FSA clearance. ONOO
generator systems
were then added to the cell culture media at a pH of 7.4. To promote
the stability of authentic added ONOO
in solution,
ONOO
(180 mM stock in 0.3 M NaOH) was added to the cell
culture media to a final pH of 7.6. Pilot studies confirmed that there
were no adverse effects of a pH of 7.6 on the cytoskeleton or on
monolayer barrier function. We also found that antioxidants such as
L-cysteine, urate, and SOD significantly prevented barrier
disruption resulting from ONOO
mimetics (data not shown),
confirming our previous findings.
In the present study, these same ONOO
mimetics also
depolymerized F-actin filaments as shown by increased G-actin and
reduced F-actin (Fig. 10A).
In contrast, antioxidants (urate, L-cysteine, SOD) almost
completely prevented both the actin oxidation and nitration (Table
1) and the actin depolymerization (Fig.
10B) that result from exposure of monolayers to
ONOO
compounds. LSCM (Fig.
11) showed that ONOO
elicited actin disruption, aggregation, and kinking (Fig.
11B). Pretreatment of the monolayers with the antioxidant
L-cysteine (Fig. 11C) protected the F-actin
cytoskeleton against disruption induced by ONOO
. The
antioxidant-treated group (C) was indistinguishable from the
control group (Fig. 11A).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 10.
Disassembly and disruption of the actin induced by
chemically synthesized peroxynitrite (ONOO ) and
ONOO donors (A) and its prevention by
antioxidants (B) in Caco-2 monolayers as determined by
immunoblotting analysis of F- and G-actin. Monolayers were preincubated
with antioxidants or in control conditions and then exposed to
authentic ONOO (30 min) or ONOO generators,
3-morpholinosydnonimine (SIN-1, 1 h) or a combination of
S-nitroso-N-acetyl penicillamine (SNAP, 6 h)
plus xanthine (X, 1 mM) and xanthine oxidase (XO, 100 mU/mL). Percent
polymerization of actin = [F / total actin pool (F + G)].
*P < 0.05 compared with vehicle. +P < 0.05 compared with ONOO or SIN-1 alone. ++P < 0.05 compared with SOD pretreated.
|
|

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 11.
Fluorescent staining of F-actin
cytoskeleton by fluorescein-conjugated phalloidin assessed by
high-resolution laser confocal microscopy from intestinal cell
monolayers incubated with (a) isotonic saline (control), (b) 0.1 mM
ONOO , or (c) L-cysteine and then
ONOO . ONOO exposure produced the
disruption, condensation, and beading of the actin "ring" of the
cytoskeleton. In contrast, the actin structure in anti-oxidant
(L-cysteine) pretreated cells appears intact and resembles
the normal architecture seen in controls. Bar = 25 µm.
|
|
Table 2 shows that ONOO
and
HOCl, like H2O2, upregulated both iNOS activity
and NO levels (compare Fig. 3, A and C, with Table 2). Indeed, iNOS upregulation occurs after the addition of other
agents that are injurious to the intestinal barrier, such as
ethanol.
 |
DISCUSSION |
Together, our present findings support our main conclusion that
the H2O2-induced disruption of the F-actin
cytoskeleton of Caco-2 cells and the consequent disruption of the
permeability barrier of Caco-2 monolayers require activation of an
iNOS-driven pathway and increased levels of RNMs such as NO and
ONOO
, which appear to mediate this damage through
nitration and oxidation of a 43-kDa actin molecule. A second
conclusion, and a novel finding, is that exposure of these intestinal
cells to oxidants, a process that models the oxidative stress that
occurs during the acute IBD attack, can, surprisingly, further increase
cellular synthesis of RNMs and ROMs. A third conclusion, also novel, is
that oxidants such as H2O2, HOCl, and
ONOO
can rapidly upregulate iNOS enzyme activity and NO levels.
Our primary conclusion is relevant to IBD. It extends our previous
investigation into the role of oxidants in the pathophysiological mechanisms of this disease. Although the primary etiology of IBD is
multifactorial, gut leakiness and diffusion of intraluminal proinflammatory antigens (e.g., bacterial products) are considered to
be reasonable initial steps for subsequent intestinal inflammation. Similarly, in our monolayer model, oxidants induced barrier
hyperpermeability. We (2) previously traced the in vitro
cause of this monolayer hyperpermeability back to disruption of the
functioning and architectural integrity of actin filaments. We now show
that iNOS upregulation and oxidation and nitration of the subunit
components of the actin cytoskeleton are a major part of the mechanism
for the disruption of the F-actin filaments. In this view, the
connection between iNOS and actin nitration is through the reaction
|
(1)
|
an idea that is supported by both the existing literature
(21, 31, 34) and our finding here that DCF fluorescence is quenched by both O
· scavengers (SOD) and by NO and
ONOO
scavengers.
Two factors further enhance the validity of this primary conclusion.
First, the conclusion is supported in the present study by three
independent lines of investigation: 1)
H2O2 concentrations that cause actin damage and
intestinal hyperpermeability simultaneously activate iNOS and increase
RNMs and oxidative stress; 2) three different exogenously
added RNMs mimicked all the effects of H2O2; and 3) both iNOS inhibitors and antioxidants that scavenge
RNMs prevented or substantially attenuated the injurious changes that resulted from exposure either to H2O2 or to RNM
compounds. Second, we found robust positive correlations between
increases in RNMs, increases in oxidative stress, RNM-associated
nitration and disruption of the F-actin cytoskeleton, and increases in
monolayer permeability. Correlation analysis showed a significant
(P < 0.05) and robust correlation between NO and
nitrotyrosine levels (r = 0.97) and between
nitrotyrosine levels and either actin disruption (r = 0.98) or actin disassembly (r = 0.94). Similar to
nitration, oxidation, as measured by either carbonyl levels or DCF
fluorescence, predicted actin disruption (r values of 0.92 and 0.96, respectively). There was also a significant positive
correlation (r = 0.95) between H2O2-induced barrier disruption (FSA) and
actin disassembly. Finally, the two markers for actin integrity (i.e.,
percentage of polymerization and percentage of normal actin) strongly
correlated with each other (r = 0.96). Although it is
possible that the increase in ONOO
levels observed after
exposure of the cells to H2O2 derived from sources other than iNOS and its reaction product NO, our data suggest
that this would likely be a relatively minor source because the iNOS
inhibitor L-NIL nearly completely abolished oxidant-induced nitration injury to the actin cytoskeleton and maintained barrier integrity. Overall, the biochemical cause of injury to the actin network appears to be the nitration and oxidation of its 43-kDa protein subunits.
It might be argued that the antioxidants L-cysteine
and urate are not specific to RNMs and might inhibit the synthesis of ONOO
(see eq. 1) by scavenging
O
· as SOD does. Although this could conceivably
occur, there would still be overwhelming evidence that NO and
ONOO
are involved in oxidant-induced damage in our model.
First, ONOO
mimetics (authentic ONOO
or
ONOO
-generating systems) mimic
H2O2. Second, nitration as measured by
nitrotyrosine formation on actin protein occurs in Caco-2 cells after
the addition of oxidants (H2O2,
ONOO
). Third, a selective iNOS inhibitor
(L-NIL) prevents nitration. Fourth, our own previous
experiments (7) involving the addition of
L-cysteine to a test tube containing authentic
ONOO
(in which L-cysteine completely
scavenged the ONOO
) and other literature (15, 22,
32-34) clearly indicate that L-cysteine and
urate are capable of scavenging RNMs. Moreover, they must be doing so
here because urate and L-cysteine prevented both the
F-actin nitration and the F-actin depolymerization that was caused when
we directly added authentic ONOO
to our monolayers.
Fifth, the free sulfhydryl groups of L-cysteine react with
ONOO
with a rate constant (5,900 M
1s
1) that is over 1,000-fold greater than
its rate constants for reaction with other oxygen species such as
H2O2 or O
· (~4
M
1s
1)(32), making it more
likely that L-cysteine is effectively scavenging ONOO
at a greater rate than O
·.
Our primary conclusion is consistent with recent studies showing
that O
· reacts rapidly with NO to generate
ONOO
in vivo (21, 31). These in vivo studies
have led to the proposal that the formation of ONOO
radical is key in the pathogenesis of IBD and a variety of other inflammatory GI and systemic disorders (23, 28, 37), but the target proteins were unclear. For example, tissue nitration, which
was detected by immunofluorescent staining of nitrotyrosine, has been
associated with the inflamed human mucosa in IBD (28, 37)
and was linked with the upregulation of iNOS (37). Some nitrated tissue proteins (e.g., SOD and glutathione) have been detected
in vivo in non-GI models such as the inflamed lung (23, 32). Moreover, it appears that ONOO
-induced tissue
nitration (nitrotyrosination) involves the addition of nitro groups to
the ortho position of tyrosine residues (22). We also
previously showed (7) that ethanol induces tubulin nitration and oxidation in vitro in monolayers of human intestinal cells. The current study suggests that actin molecules and the F-actin
cytoskeleton are key target proteins of oxidant-induced nitration. On
the basis of our findings with ethanol (7, 8), it seems
likely that tubulin and the microtubule cytoskeleton are also key
target proteins. These conjectures are further supported by previous
studies (2, 6) in which we showed that phalloidin and
taxol, agents that prevent oxidative damage to the F-actin and the
microtubule cytoskeletons, respectively, also prevent barrier disruption.
Interestingly, cytoskeletal injury does not need to affect all cells in
the monolayer to elicit intestinal leakiness. The data presented in
Fig. 6 indicate that significant damage occurs when only ~50% of
cells in the monolayer no longer show a normal actin cytoskeleton. This
is accomplished under oxidative conditions in which there is a 65%
increase in actin nitration (Fig. 9A).
Finally, our primary conclusion is consistent with our most recent in
vivo studies (48) in which immunoblotting analysis of the
mucosal pinch biopsy specimens of inflamed intestinal tissues from IBD
patients showed increased tissue levels of NO and nitrotyrosination of actin.
Our second conclusion is also relevant to IBD and suggests a
novel positive feedback mechanism that could, if it occurred in vivo,
very likely overwhelm endogenous antioxidant defenses and either
initiate or sustain the acute IBD attack. This positive feedback is
seen in the ability of three separate oxidants
(H2O2, HOCl, and ONOO
) to
upregulate iNOS, which then synthesizes NO and ONOO
.
Although the reasons behind the presence of such a positive feedback
mechanism in our model are unclear (oxidants may be activating cellular
stress responses), the existence of this mechanism is consistent with
the current characterization of the pathophysiology of IBD (26,
28). This is especially true for the transition from the
inactive to active (flare-up) phases of inflammation in IBD in which
intestinal oxidants and proinflammatory molecules periodically create a
vicious cycle that leads to sustained inflammation and tissue damage.
In particular, the natural course of IBD involves recurrent episodes of
the inactive phase (in which there are no neutrophils) followed by
acute exacerbation (flare-up) that is characterized by mucosal
infiltration of large numbers of leukocytes including neutrophils.
These plasma cells are capable of producing large quantities of ROMs
(e.g., H2O2 and HOCl) and RNMs (e.g., ONOO
), reactive species that create a vicious cycle and
sustain an inflammatory cascade. A positive feedback loop, such as the
one we observed in Caco-2 cells, could play a key role in establishing such a vicious cycle.
Our third conclusion is that increases in the level or activity
of iNOS can occur rapidly. This conclusion is supported by parallel
increases in three separate variables: iNOS protein levels, iNOS enzyme
activity, and NO levels. The findings of recent studies in endothelial
cells, as well as one in vivo study in rat gastric mucosal cells, are
also consistent with our finding of rapid iNOS upregulation
(41-43). In the study that used isolated rat gastric mucosal cells, low basal levels of iNOS were noted in control (untreated) mucosa (41), whereas after challenge with
endotoxin, significant increases in iNOS activity were detected in the
mucosal cells within 1 h, followed by peak levels at 2-4 h.
Similarly, other studies on endothelial cells showed detectable levels
of iNOS activity as early as 60-90 min after
H2O2 (0.1-1 mM) challenge (42,
43). In yet another study in endothelial cells, a slight basal
expression of iNOS protein (and iNOS mRNA as detected by RT-PCR) was
shown in unstimulated cells (44). Furthermore, it seems
unlikely that oxidant-induced increases in cNOS activity are occurring
and confounding our finding that Ca2+-independent iNOS is
upregulated, because we found that neither oxidants nor
L-NIL affect Ca2+-dependent cNOS activity.
A question that remains to be answered is how iNOS might be activated
so rapidly. We now suggest three mechanisms by which the rapid iNOS
upregulation might occur: protein synthesis starting from a preexisting
mRNA pool; upregulation of inactive iNOS enzyme molecules by any of
several well-known cellular mechanisms such as
phosphorylation-dephosphorylation; and iNOS dimerization. The first
mechanism requires a basal constitutive level of iNOS mRNA in
unstimulated cells, as was suggested by a recent study in endothelial cells (44). In general, protein expression (i.e.,
transcription) from a "standing pool of mRNA" does not require more
than 30-40 min.
A second proposed mechanism is the phosphorylation of the iNOS enzyme
as a means of rapidly regulating its enzymatic activity. NOS contains
consensus sequences for sites of protein phosphorylation (45,
46); tyrosine phosphorylation of Ca2+-independent
NOS has been shown in vitro and in endothelial cells after a variety of
stimuli, and it was proposed that this mechanism could rapidly
regulate the activity of NOS (45, 46).
A third alternative mechanism is the rapid assembly of the two known
monomeric domains of iNOS into an active dimer, which is known to be
required for NOS catalytic activity. Specifically, pools of inactive
monomeric iNOS would be available from a standing intracellular protein
pool in unstimulated cells. These monomers can be rapidly assembled by
an appropriate stimulus into an active dimer (47). Future
studies will be needed to investigate which of these mechanisms is
operative in our model and in intestinal cells in general.
Although ONOO
is relatively short-lived at
physiological pH (7.4), we believe that our methods, results, and
conclusions drawn from the ONOO
systems that we have
employed are valid for several reasons. 1) Our findings are
consistent with several reports from the literature that indicate that
ONOO
or its footprints have been detected in vivo in
inflamed mucosal tissue from patients with IBD as well as from patients
with other systemic inflammatory disorders such as in the lung
(23, 26, 28, 35, 37). For example, ONOO
has
been detected in the inflamed colonic mucosa by immunofluorescence analysis (28). Thus, although ONOO
is
short-lived, its footprints have been detectable in vivo under a
variety of pathophysiological conditions and, apparently, enough ONOO
is around for a long enough time for this to occur.
2) ONOO
generator systems (SIN-1 and
SNAP-xanthine-xanthine oxidase were used in our studies) caused
nitration damage to actin and to the permeability barrier of our
monolayers at pH 7.4. Both of these models are known to spontaneously
generate ONOO
in vitro (25, 34). Moreover,
the extent of the damage was equivalent to damage induced by oxidants
(H2O2 or authentic ONOO
at pH
7.6). 3) Added authentic ONOO
caused a degree
of damage at pH 7.6 similar to that caused by ONOO
generators at pH 7.4. At pH 7.6, ONOO
decreased over 30 min from 100% of added ONOO
to ~38% as our laboratory
previously reported (7). Thus a substantial fraction of
the added ONOO
remains in contact with our monolayers and
could very well lead to injury.
In summary, our studies to date indicate that the disruption of
intestinal barrier function induced by oxidants is caused by iNOS
upregulation, RNMs, and oxidative injury to the actin cytoskeleton and
the microtubule cytoskeleton. If this mechanism can be demonstrated in
vivo, then our in vitro findings would suggest intracellular mechanisms
(e.g., iNOS inhibitors and ONOO
scavengers) that might
serve as targets for the development of novel therapies for IBD.
This work was supported in part by a grant from Rush University
Medical Center and the American College of Gastroenterology.
Portions of this work were presented in abstract form at the annual
meeting of the American Gastroenterological Association in San Diego,
CA, 2000.
Address for reprint requests and other correspondence: A. Banan, Rush Univ. Medical Ctr., Div. of Digestive Diseases, 1725 W. Harrison, Ste. 206, Chicago, IL 60612 (E-mail:
ali_banan{at}rush.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 5 October 2000; accepted in final form 24 January 2001.